TOVX: Theriva Biologics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Theriva Biologics Inc (TOVX).
$4.87M Market Cap.
TOVX Market Cap. (MRY)
TOVX Shares Outstanding (MRY)
TOVX Assets (MRY)
Total Assets
$35.35M
Total Liabilities
$16.29M
Total Investments
$0
TOVX Income (MRY)
Revenue
$0
Net Income
-$25.65M
Operating Expense
$26.35M
TOVX Cash Flow (MRY)
CF Operations
-$16.94M
CF Investing
-$1.00K
CF Financing
$5.50M
TOVX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $35,352,000 (-35.98%) | $55,219,000 (-23.16%) | $71,861,000 (2.13%) | $70,365,000 (736.68%) |
Assets Current | $16,281,000 (-40.59%) | $27,403,000 (-39.80%) | $45,520,000 (-33.89%) | $68,858,000 (767.89%) |
Assets Non-Current | $19,071,000 (-31.44%) | $27,816,000 (5.60%) | $26,341,000 (1647.91%) | $1,507,000 (216.60%) |
Goodwill & Intangible Assets | $0 (0%) | $5,700,000 (3.17%) | $5,525,000 (0%) | $0 (0%) |
Shareholders Equity | $19,067,000 (-48.42%) | $36,963,000 (-28.68%) | $51,830,000 (-20.76%) | $65,408,000 (1472.10%) |
Property Plant & Equipment Net | $1,542,000 (-29.30%) | $2,181,000 (41.26%) | $1,544,000 (4.04%) | $1,484,000 (227.59%) |
Cash & Equivalents | $11,705,000 (-49.72%) | $23,279,000 (-44.42%) | $41,885,000 (-37.79%) | $67,325,000 (981.18%) |
Accumulated Other Comprehensive Income | -$1,178,000 (-3781.25%) | $32,000 (104.71%) | -$679,000 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $859,000 (11.56%) | $770,000 (-15.85%) | $915,000 (74.62%) | $524,000 (-40.86%) |
Accumulated Retained Earnings (Deficit) | -$334,971,000 (-8.29%) | -$309,318,000 (-6.31%) | -$290,969,000 (-7.26%) | -$271,284,000 (-9.35%) |
Tax Assets | $3,228,000 (78.15%) | $1,812,000 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $2,376,000 (31.13%) | $1,812,000 (11.99%) | $1,618,000 (0%) | $0 (0%) |
Total Debt | $1,565,000 (-27.34%) | $2,154,000 (28.14%) | $1,681,000 (10.09%) | $1,527,000 (222.83%) |
Debt Current | $600,000 (9.09%) | $550,000 (101.47%) | $273,000 (120.16%) | $124,000 (-56.79%) |
Debt Non-Current | $965,000 (-39.84%) | $1,604,000 (13.92%) | $1,408,000 (0.36%) | $1,403,000 (654.30%) |
Total Liabilities | $16,285,000 (4.92%) | $15,522,000 (-10.26%) | $17,297,000 (248.94%) | $4,957,000 (57.27%) |
Liabilities Current | $7,585,000 (12.57%) | $6,738,000 (-4.56%) | $7,060,000 (98.65%) | $3,554,000 (19.82%) |
Liabilities Non-Current | $8,700,000 (-0.96%) | $8,784,000 (-14.19%) | $10,237,000 (629.65%) | $1,403,000 (654.30%) |
TOVX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $7,396,000 (3.88%) | $7,120,000 (-27.77%) | $9,858,000 (52.27%) | $6,474,000 (28.73%) |
Research & Development Expense | $12,031,000 (-15.93%) | $14,311,000 (22.08%) | $11,723,000 (50.29%) | $7,800,000 (52.02%) |
Operating Expenses | $26,346,000 (22.93%) | $21,431,000 (-0.70%) | $21,581,000 (51.19%) | $14,274,000 (40.49%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | -$1,640,000 (-15.09%) | -$1,425,000 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$25,653,000 (-39.81%) | -$18,349,000 (6.79%) | -$19,685,000 (-37.97%) | -$14,268,000 (-41.04%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | -$1,000 (98.63%) |
Net Income | -$25,653,000 (-39.81%) | -$18,349,000 (6.79%) | -$19,685,000 (-37.98%) | -$14,267,000 (-42.06%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $340,000 (-96.19%) | $8,922,000 (254.89%) |
Net Income Common Stock | -$25,653,000 (-39.81%) | -$18,349,000 (8.37%) | -$20,025,000 (13.64%) | -$23,189,000 (-84.67%) |
Weighted Average Shares | $1,348,126 (109.24%) | $644,282 (5.09%) | $613,093 (25.76%) | $487,500 (541.07%) |
Weighted Average Shares Diluted | $1,348,126 (109.24%) | $644,282 (5.09%) | $613,093 (25.76%) | $487,500 (541.07%) |
Earning Before Interest & Taxes (EBIT) | -$25,653,000 (-28.34%) | -$19,989,000 (5.31%) | -$21,110,000 (-47.96%) | -$14,267,000 (-42.06%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$26,346,000 (-22.93%) | -$21,431,000 (0.70%) | -$21,581,000 (-51.19%) | -$14,274,000 (-40.49%) |
TOVX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$1,000 (99.50%) | -$202,000 (95.40%) | -$4,396,000 (-31300.00%) | -$14,000 (-55.56%) |
Net Cash Flow from Financing | $5,496,000 (779.36%) | $625,000 (132.38%) | -$1,930,000 (-102.61%) | $74,002,000 (2103.10%) |
Net Cash Flow from Operations | -$16,937,000 (10.84%) | -$18,996,000 (0.45%) | -$19,082,000 (-48.04%) | -$12,890,000 (-5.93%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$11,574,000 (37.79%) | -$18,606,000 (26.77%) | -$25,408,000 (-141.59%) | $61,098,000 (792.88%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$4,280,000 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$1,000 (99.50%) | -$202,000 (-74.14%) | -$116,000 (-728.57%) | -$14,000 (-55.56%) |
Issuance (Repayment) of Debt Securities | -$67,000 (10.67%) | -$75,000 (94.55%) | -$1,376,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $5,563,000 (150.70%) | $2,219,000 (870.49%) | -$288,000 (-100.39%) | $74,002,000 (2103.10%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$132,000 (-300.00%) | -$33,000 (-3.13%) | -$32,000 (0%) | $0 (0%) |
Share Based Compensation | $671,000 (21.56%) | $552,000 (16.21%) | $475,000 (14.18%) | $416,000 (18.86%) |
Depreciation Amortization & Accretion | $589,000 (12.62%) | $523,000 (95.15%) | $268,000 (208.05%) | $87,000 (-56.72%) |
TOVX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -101.60% (-136.83%) | -42.90% (-26.92%) | -33.80% (-7.30%) | -31.50% (-109.97%) |
Return on Average Assets (ROAA) | -61.60% (-110.24%) | -29.30% (-17.67%) | -24.90% (18.89%) | -30.70% (77.34%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -135.60% (-33.33%) | -101.70% (25.55%) | -136.60% (87.19%) | -1066.10% (-187.52%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.09 (75.66%) | -0.38 (-8.93%) | -0.35 (75.79%) | -1.43 (-147.07%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.26 (28.79%) | 0.2 (42.45%) | 0.14 (-74.73%) | 0.55 (134.25%) |
Debt to Equity Ratio (D/E) | 0.85 (103.33%) | 0.42 (25.75%) | 0.33 (339.47%) | 0.08 (111.50%) |
Earnings Per Share (EPS) | -19.03 (33.18%) | -28.48 (13.04%) | -32.75 (31.05%) | -47.5 (71.21%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -12.56 (57.84%) | -29.8 (4.84%) | -31.31 (-18.30%) | -26.47 (83.47%) |
Book Value Per Share (BVPS) | 14.14 (-75.35%) | 57.37 (-32.14%) | 84.54 (-36.99%) | 134.17 (314.04%) |
Tangible Assets Book Value Per Share (TABVPS) | 26.22 (-65.88%) | 76.86 (-28.97%) | 108.2 (-25.04%) | 144.34 (30.51%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 1 (-50.00%) | 2 (0.00%) | 2 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.4 (-64.57%) | 1.11 (-44.31%) | 2 (-17.98%) | 2.44 (1194.62%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 2.15 (-47.23%) | 4.07 (-36.93%) | 6.45 (-66.72%) | 19.38 (624.30%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$16,938,000 (11.77%) | -$19,198,000 (0.00%) | -$19,198,000 (-48.78%) | -$12,904,000 (-5.97%) |
Enterprise Value (EV) | -$9,903,714 (54.37%) | -$21,704,907 (47.97%) | -$41,719,121 (-20.52%) | -$34,617,021 (-1679.63%) |
Earnings Before Tax (EBT) | -$25,653,000 (-28.34%) | -$19,989,000 (5.31%) | -$21,110,000 (-47.96%) | -$14,267,000 (-42.06%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$25,064,000 (-28.76%) | -$19,466,000 (6.60%) | -$20,842,000 (-46.98%) | -$14,180,000 (-44.08%) |
Invested Capital | $17,627,000 (-18.60%) | $21,656,000 (13.55%) | $19,072,000 (1782.72%) | $1,013,000 (426.77%) |
Working Capital | $8,696,000 (-57.92%) | $20,665,000 (-46.27%) | $38,460,000 (-41.11%) | $65,304,000 (1214.49%) |
Tangible Asset Value | $35,352,000 (-28.61%) | $49,519,000 (-25.35%) | $66,336,000 (-5.73%) | $70,365,000 (736.68%) |
Market Capitalization | $4,869,286 (-33.57%) | $7,330,093 (1.72%) | $7,205,879 (-79.95%) | $35,941,979 (369.37%) |
Average Equity | $25,247,750 (-40.94%) | $42,746,000 (-27.84%) | $59,236,500 (-19.64%) | $73,711,250 (1953.67%) |
Average Assets | $41,645,000 (-33.39%) | $62,524,750 (-22.30%) | $80,471,500 (6.66%) | $75,448,750 (713.86%) |
Invested Capital Average | $18,915,000 (-3.75%) | $19,651,000 (27.18%) | $15,451,750 (1054.62%) | $1,338,250 (262.31%) |
Shares | 2,782,449 (308.16%) | 681,711 (7.57%) | 633,762 (19.99%) | 528,170 (560.43%) |
